Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen

Biochimica et Biophysica Acta- Protein Structure and Molecular Enzymology

Volumn 1480, Issue 1-2, 2000, Pages 311-320

  Léránt, István ^a   Kolev, Krasimir ^a   Gombás, Judit ^a   Machovich, Raymund ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Diabetes mellitus; Fibrinolysis; Methylglyoxal; Plasmin(ogen)

Indexed keywords

ENZYME PRECURSOR; METHYLGLYOXAL; PLASMIN; PLASMINOGEN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TRYPSIN; UROKINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FIBRINOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; CATALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRINOLYSIS; KINETICS; LYSINE; MALE; PLASMIN; PLASMINOGEN; PYRUVALDEHYDE; RATS; RATS, WISTAR; SPECTROMETRY, FLUORESCENCE;

EID: 0343953093     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(00)00083-2     Document Type: Article

References (31)

1. Krolewski A.S., Warram J.H., Rand L.I., Kahn C.R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N. Engl. J. Med. 317:1987;1390-1398.
2. Van der Jagt D.L., Robinson B., Taylor K.K., Hunsaker K.K. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem. 267:1992;4364-4369.
3. Thornalley P.J., Hooper N.I., Jennings N.I., Florkowski C.M., Jones A.F., Lunec J., Barnett A.H. The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Res. Clin. Pract. 7:1989;115-120.
4. Kalapos M.P. Methylglyoxal toxicity in mammals. Toxic. Lett. 73:1994;3-24.
5. Gonzalez F.J. The molecular biology of cytochrome. Pharmacol. Rev. 40:1988;243-288.
6. Richard J.P. Mechanism for the formation of methylglyoxal from triosephosphates. Biochem. Soc. Trans. 21:1993;549-553.
7. Kalapos M.P. Studies on ethanol-inducible cytochrome P-450 in rabbit liver, lungs and kidneys. Biochem. Educ. 20:1992;27-29.
8. L.A. Erickson, Regulation of vascular fibrinolysis, in: R. Machovich (Ed.), Blood Vessel Wall and Thrombosis, Vol. I, CRC Press, Boca Raton, 1988, pp. 221-233.
9. Ueng T.H., Friedman F.K., Miller H., Park S.S., Gelboin H.V., Alvares A.P. Studies on ethanol-inducible cytochrome P-450 in rabbit liver, lungs and kidneys. Biochem. Pharmacol. 36:1987;2689-2691.
10. Ueng T.H., Tsai J.N., Ju J.N., Ueng J.N., Iwasaki M., Guengrich F.P. Effects of acetone administration on cytochrome P-450-dependent monooxygenases in hamster liver, kidney, and lung. Arch. Toxicol. 65:1991;45-51.
11. Philips S.A., Thornalley P.J. Formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur. J. Biochem. 212:1993;101-105.
12. Racker E. The mechanism of action of glyoxalase. J. Biol. Chem. 190:1951;685-696.
13. Deutsch D.G., Mertz E.T. Plasminogen purification from human plasma by affinity chromatography. Science. 170:1970;1995-1996.
14. Kolev K., Owen W.G., Machovich R. Dual effect of synthetic plasmin substrates on plasminogen activation. Biochim. Biophys. Acta. 1247:1995;239-245.
15. Cheung S.T., Fonda M.L. Reaction of phenylglyoxal with arginine. The effect of buffers and pH. Biochem. Biophys. Res. Commun. 90:1979;940-947.
16. Krymkiewicz N. Reactions of methylglyoxal with nucleic acids. FEBS Lett. 29:1973;51-54.
17. Riley M.L., Harding J.J. The reaction of methylglyoxal with human and bovine lens proteins. Biochim. Biophys. Acta. 1270:1995;36-43.
18. Kolev K., Léránt I., Tenekejiev K., Machovich R. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors. J. Biol. Chem. 254:1994;4027-4032.
19. Chase T., Shaw E. Titration of trypsin, plasmin and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl. Methods Enzymol. 19:1970;20-27.
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Fields R. The rapid determination of aminogroups with TNBS. Methods Enzymol. 25:1972;464-468.
22. Smith R.E., MacQuarrie R. A sensitive fluorometric method for the determination of arginine using 9,10-Phenanthrenequinone. Anal. Biochem. 90:1978;246-255.
23. Gruber A., Mori E., del Zoppo G.J., Waxman L., Griffin J.H. Alteration of fibrin network by activated protein C. Blood. 83:1994;2541-2548.
24. Kolev K., Komorowicz E., Owen W.G., Machovich R. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neutrophil leukocyte elastase and cathepsin G. Thromb. Haemost. 75:1996;140-146.
25. Westwood M.E., McLellan A.C., Thornalley P.J. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. J. Biol. Chem. 269:1994;32293-32298.
26. Shipanova I.N., Glomb M.A., Nagaraj R.H. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys. 344:1997;29-36.
27. Machovich R., Litwiller R.D., Owen W.G. Requirement of zymogen modification for activation of porcine plasminogen. Biochemistry. 31:1992;11558-11561.
28. Lo T.W.C., Westwood M.E., McLellan A.C., Selwood T., Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N-α-acetylarginine, N-α-acetylcysteine, and N-α-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269:1994;32299-32305.
29. Lee J.Y., Park J.B., Lee T.H. Reaction mechanism of protein crosslinking by methylglyoxal. Korean J. Biochem. 23:1991;231-235.
30. Huber K., Kirchheimer J.C., Korninger C., Binder B.R. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. Thromb. Res. 62:1991;491-500.
31. Köhler M., Sen S., Miyashita C., Hermes R., Pindur G., Heiden M., Berg G., Morsdorf S., Leipnitz G., Zeppezauer M. Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain plasminogen activator (tcu-PA) in patients with acute myocardial infarction. Thromb. Res. 62:1991;75-81.